DECEMBER 20, 2023

Beccar Varela and Allende y Brea advise on the acquisition of CEIMIC by Phenna Group.


Buenos Aires, December 20th, 2023. On December 1st, 2023, Phenna Group acquired CEIMIC Life Sciences Testing Group, a company specialized in life sciences testing that, after a long period of expansion, now has one of the main laboratory networks in the Americas, offering quality analytical services, sampling, technology, and logistics spanning seven Latin American countries, Dominican Republic, and the USA.

Phenna Group has signed its fourteenth agreement of 2023 by acquiring CEIMIC. This acquisition marks an important milestone for the company as it is their first in the Latin American region. It is also a significant step towards their current growth strategy.

Headquartered in Nottingham, UK, Phenna Group aims to invest in and partner with selected niche, independent Testing, Inspection, Certification, and Compliance (TICC) companies providing world-class services across a wide range of sectors. Founded in 2017 and headquartered in Sao Paulo, Brazil, CEIMIC is a specialized life sciences testing company with more than 300 expert employees. CEIMIC’s range of services is exhaustive and covers the environmental, air quality, food, and pharmaceutical end markets, where they focus on the health and quality control of food in all its processes to guarantee safety and consumer protection.

Counsel to Phenna Group

Beccar Varela advised Phenna Group on CEIMIC’s Argentine branch acquisition. The team was led by partners Tomás Allende and Pedro Silvestri and was comprised of associates María Inés Cappelletti and Cruz Uranga.

Furthermore, the company was advised by the legal firms RSM and Avonhurst.

Counsel to CEIMIC Life Sciences Testing Group

Allende y Brea advised CEIMIC in Argentina. The team was led by partners Raúl Fratantoni and Marcos Patrón Costas, and comprised associates Gonzalo Gándara, Jazmín Abraham Poppe, Gaspar Leveratto, and May Steward.